{"title":"答复治疗囊性纤维化加重的类固醇：我们选对病人了吗？","authors":"Valerie Waters, Bradley Quon, Felix Ratjen","doi":"10.1183/13993003.01713-2024","DOIUrl":null,"url":null,"abstract":"<sec><st>Extract</st>\n<p>We thank D. Beinart and co-workers for their insightful comments and important question regarding the PIPE Study of oral prednisone as adjunctive therapy for pulmonary exacerbations in people with cystic fibrosis (CF) [1].</p>\n</sec>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":"222 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply to: Steroids in cystic fibrosis exacerbations: are we picking the right patients?\",\"authors\":\"Valerie Waters, Bradley Quon, Felix Ratjen\",\"doi\":\"10.1183/13993003.01713-2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<sec><st>Extract</st>\\n<p>We thank D. Beinart and co-workers for their insightful comments and important question regarding the PIPE Study of oral prednisone as adjunctive therapy for pulmonary exacerbations in people with cystic fibrosis (CF) [1].</p>\\n</sec>\",\"PeriodicalId\":12265,\"journal\":{\"name\":\"European Respiratory Journal\",\"volume\":\"222 1\",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2024-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Respiratory Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.01713-2024\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.01713-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
摘录我们感谢 D. Beinart 及其合作者提出的富有洞察力的意见和重要问题，这些意见和问题涉及将口服泼尼松作为囊性纤维化 (CF) 患者肺部恶化的辅助疗法的 PIPE 研究 [1]。
Reply to: Steroids in cystic fibrosis exacerbations: are we picking the right patients?
Extract
We thank D. Beinart and co-workers for their insightful comments and important question regarding the PIPE Study of oral prednisone as adjunctive therapy for pulmonary exacerbations in people with cystic fibrosis (CF) [1].
期刊介绍：
The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
